Compare ENVB & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENVB | DSS |
|---|---|---|
| Founded | 1994 | 1984 |
| Country | United States | United States |
| Employees | 6 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 5.1M |
| IPO Year | 2000 | 2020 |
| Metric | ENVB | DSS |
|---|---|---|
| Price | $1.41 | $0.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 27.5K | 26.8K |
| Earning Date | 11-13-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.45 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $39,914,675.00 | $2,085,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $43.35 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.17 | $0.36 |
| 52 Week High | $795.00 | $1.86 |
| Indicator | ENVB | DSS |
|---|---|---|
| Relative Strength Index (RSI) | 44.66 | 50.80 |
| Support Level | $1.35 | $0.49 |
| Resistance Level | $1.55 | $0.57 |
| Average True Range (ATR) | 0.09 | 0.05 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 22.73 | 60.66 |
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia. Product packaging manufactures and sells sophisticated custom folding cartons, mailers, photo sleeves, and complex three-dimensional direct mail solutions. The biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the Securities and Investment Management.